Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Ehr And Pharmacy


Published on

Group presentation that I created on PowerPoint

  • Be the first to comment

  • Be the first to like this

Ehr And Pharmacy

  1. 1. Cheryl, Regina,Carolny and Gary
  2. 2. • Explain the goals of the pharmacy department in an EHR• Discuss the role of the pharmacist in diverse healthcare settings• Justify verification, drug packaging, and bar-coding• Discuss the differences between CPOE and e-Prescribing
  3. 3. Patient-Centered SafetyEfficiencyCost Effectiveness
  4. 4.  Building and Maintaining of Medication Order Sets Implementation of Drug-Drug, Drug- Allergy, and Drug-Formulary Checks Management and Analysis of Medication Alerts Medication Management Therapy Medication Reconciliation
  5. 5.  Pharmacists’ are familiar order entry systems Interfacing can include order driven dispensing cabinets and robotics Bar-coding and smart pumps can be integrated into pharmacy information systems
  6. 6. Drug Allergy Lists Drug-Drug DrugInteractions Formulary checks
  7. 7. Clinical Decision SupportDrug Knowledge Base
  8. 8. • World Health Organization estimates that up to 50% of patients do not take their prescribed medications(3)• Greatest potential for morbidity reduction is the resumption of home medications during acute stays and at discharge(4)• Medication reconciliation is a complex process
  9. 9. Medications are reviewed by physicians, pharmacists, and nursesStandardized icons indicate a status or problemEvidence LinksReference Information
  10. 10. Chart Before Verification is used in emergency situations when a delay is harmful to the patientChart Before Verification has NO safety checks
  11. 11.  Centralized pharmacy operations Streamlined drug distribution and dispensing Repackaging of bulk medications into unit-dosed portions Creating specialized complex mixtures Integration of PharmNet with bar-code printing ( makes BCMA possible)
  12. 12.  Real-Time Check that identifies the correct patient, medication, dose, time, and delivery method Real-Time documentation of medication Prevents against: - Wrong patient, wrong medication, duplicate dosing, incorrect route of delivery Calculates sliding scale dosing
  13. 13. o CPOE occurs in the inpatient setting, while e-Prescribing occurs in the outpatient setting Both involve the transmission of physician orderso CPOE and e-Prescribing featureso HIMMS defines e-prescribing as the electron generation of prescriptions through an automated data entry processing system utilizing software, and a transmission
  14. 14. By using a computer or hand held devicea prescriber can electronically: Access a patient’s prescription benefit information Access a patient’s consent Access a patient’s current and past prescriptions Electronically route prescriptions to the patient’s pharmacy
  15. 15. Advantages Accuracy/Safety Efficiency Compliance Lower healthcare costsDisadvantages Prohibition of e-prescribing controlled substances Difficulty recording tapering doses Entering pharmacy names into the system
  16. 16.  Remote ICU pharmacy services utilized More portable devices Increasing use of bar-coding technology for specialty, complex, and high-risk medication administration Certified Pharmacy Information Systems and possibly other healthcare equipment
  17. 17.  The goals of pharmacy include patient- centered safety, efficiency within the pharmacy department, and cost effectiveness. Pharmacists have diverse roles. These include inpatient pharmacists, retail pharmacists, and pharmacy consultants. Verification, drug packaging and bar-coding have made the pharmacy efficient and safer for patients. Hospitals use CPOE, while clinics use e- prescribing for medication management.
  18. 18. 1., PSW Facilitates Dialogue among Wisconsin’s Hospital Pharmacy Directors and Managers, df, Retrieved 11/19/2010.2., The Pharmacist’s Guide to Meaningful Use, meaningful-use, Retrieved 11/19/2010.3., McKesson and Pfizer Partner to Support Pharmacists’ Role in Patient Care, us/, Retrieved 11/19/2010.4., Evaluation of Patient Interventions and Recommendations by a Transitional Care Pharmacist, K Bruce Bayley et al, Therapeutics and Clinical Risk Management 2007:3(4) 695-703.5., APHA Comments to ONCHIT Policy Committee, APhACommentstoONCHITPolicyCommitteeonERxandMeaningfulUse0 12710FinalwithAttachments[1].pdf.AdobeReader, Retrieved 11/18/2010.
  19. 19. 6., Letters to the HIT Policy Committee Information Exchange Workgroup, http://APHA CommentstoONCHITPolicyCommitteeonERxandMeaningfulUse01271 0FinalwithAttachment[1].pdf.Adobe Reader, Retrieved 11/18/2010.7., McKesson and Pfizer Partner to Support Pharmacist’s Role in Patient Care, wsroom/Press%Retrie2Brleases%, Retrieved 11/18/2010.8., Letters to the Centers for Medicare Medicaid Services, CONTENTID=22813&TEMPLATE=/CM/ContentDisplay.cfm, Retrieved 11/18/2010.9., Letter to Drug Enforcement Administration Attn: DEA Federal Register Representative/ODL,,APhACommnetstoONCHITPolicyCommitteeon ERxandMeaningfulUse01271FinalwithAttachments[1].pdf.AdobeRea der, Retrieved 11/18/2010.
  20. 20. 10., Letter to ONCHIT Attn: Certification Programs Proposed Rule, acy%20Organizations%20Joint%20letter%20t o200NC%20on..., Retrieved 11/18/2010.